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In a  preceding paper  1 it was shown that the subcutaneous injection 
of killed pneumococci in doses comparable  to  those employed in man 
will not protect monkeys against pneumococcus pneumonia of homol- 
ogous or  heterologous  type.  The aim of the present  study has  been 
to determine the prophylactic value  of  a  vaccine  composed of living 
pneumococci" 
The  conviction,  based  on  considerable  experimental  evidence, has 
long been held by immunologists that a  living virus stimulates a  more 
effective resistance to infection than a  killed virus. 
Metchnikoff and Besredka,  2 in their studies on typhoid vaccination in the chim- 
panzee, found that very little protection was conferred by vacdnation with dead 
typhoid bacilli , whereas animals vaccinated with small amounts of living cultures 
were etficiently protected.  Haffkine's  s  method of vaccination against  cholera 
consisted in the injection of 0.2 to 0.05 co. of living culture of the cholera vibrio, 
first an attenuated culture being used and 5 days later a more virulent one.  As 
early as 1893 Haffldne and his coworkers vaccinated 40,000 people in India by this 
method and obtained, on the whole, encouraging  results.  Kolle and Otto,  4 after 
experiments upon monkeys and other animals,  concluded that dead plague bacilli 
were much inferior to attenuated living cultures for prophylactic vaccination. 
1 Cecil, R. L., and Blake, F. G., J. Exp. Med., 1920, xxxi, 519. 
2 Metchnikoff, E., and Besredka, A., Ann. Inst. Pasteur, 1911, xxv,  193; 1913, 
xxvii, 597. 
3 Haffkine, W. M., Bull. Inst..Pasteur,  1906, iv, 825. 
4 Kolle,  W., and Otto, R., Deutsch. reed. Woch., 1903, xxix,  493; Z.  Hyg.  u, 
Infectionskrankh., 1903, xlv, 507. 
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Strong 5  made a thorough study of the various methods of plague vaccination and 
concluded that the most efficient method was immunization with attenuated liv- 
ing cultures.  He showed that when carefully done this method can be employed 
in human beings. 
The investigations  referred  to above indicate  that  for the diseases 
of bacillary  origin  at  least,  living  vaccines are in many ways prefer- 
able to dead cultures. 
The  experiments  included  in  this study may  be divided  into  two 
groups:  (1) vaccination with a living virulent culture of Pneumococcus 
Type I, and (2) vaccination with a living avirulent culture of Pneumo- 
coccus Type I. 
EXPERIM~.NTAL. 
Two  species  of  monkeys  were  used  in  this  investigation,  Cebus 
capucinus and Macacus syrichtus. 
Method of Vaccination.--The  inoculations  were  administered  sub- 
cutaneously  in  the  abdominal  wall.  In  the  experiments  with  the 
virulent  culture the dose of vaccine was in  all  instances 0.001  cc. of 
an  18 hour  broth  culture  diluted  to  1 cc.  with normal  salt solution. 
This amount of culture contained approximately 400,000 pneumococci. 
In vaccinating with the avirulent strain  a  dose of  1 to 2  cc. of undi- 
luted broth culture was employed. 
Reactions.--The  local reaction  to living pneumococcus vaccine was 
very mild in the monkeys which were studied,  consisting of merely a 
slight  induration,  free  from  redness  and  tenderness.  The  constitu- 
tional reaction depended, on the one hand, upon the dose and virulence 
of the culture, and, on the other hand,  upon the individual resistance 
of the monkey.  The latter is a  factor of considerable variation.  As 
the experiments will show, the constitutional  reactions varied widely 
in severity, from no reaction whatever to a  fatal pneumococcus sep- 
ticemia. 
The  resistance  of  the  vaccinated  monkeys  to  experimental  pneu- 
monia was tested 2 or 3 weeks after vaccination by the intratracheal 
injection of virulent pneumococci, as described in Paper I.  6 
5 Strong, R. P., ]. Med. Research, 1908, xiii, 325. 
6 Blake, F. G., and Cecil, R. L., J. Exp. Med., 1920, xxxi, 403. RUSSELL L. CECIL AND  FRANCIS G. BLAKE  659 
Vaccination with a Living Virulent  Culture of Pneumococcus. 
The strain of pneumococcus used as a  vaccine in  this group of ex- 
periments was a  highly virulent Pneumococcus Type I  which  killed  a 
mouse regularly in doses of 0.0000001  cc. of broth culture.  The same 
strain  was  used  for  the  intratracheal  injections,  and  when  injected 
into  the  trachea of monkeys in doses of 0.000001  cc. of broth culture 
would produce in practically every instance a  classic lobar pneumonia. 
Reaction  of Monkeys  to  Subcutaneous  Injection  of  Living  Virulent 
Pneumococci.--The  first  monkey  vaccinated  with  a  living  virulent 
pneumococcus  was  studied  in  considerable  detail.  The  protocol 
therefore will be reported in  full. 
Experiment/,--Monkey 7.  Cebus  capucinus, female; weight, 1,430gm.  Mar. 
7,  1919, 10.30 a.m.  Well and active.  Subcutaneous injection of  0.001 cc.  of 
18 hour broth  culture  of Pneumococcus  Type I.  1.30  p.m.  Well and active. 
Blood culture: 0.5 cc. in broth, Pneumococcus Type I; 0.5 cc. in agar plate, 14 
colonies of Pncumococcus Type I.  4.30 p.m.  Appears well and active:  Blood 
culture: 0.5 cc. in broth, Pneumococcus Type I; 0.5 cc. in agar plate, 84 colonies 
of Pneumococcus  Type I.  7.30 p.m.  Appears well and active.  Mar. 8, 10.30 
a.m.  Appears well and active.  Blood culture: 0.5 cc. in broth, Pneumococcus 
Type I; 0.5  cc. in  agar  plate,  800  colonies  (approximately) of Pneumococcus 
Type I.  Mar. 9.  Appears well and active.  Mar. 10, 9 a.m.  Monkey quiet at 
times,  restless  at  times; evidently becoming sick.  10.30 a.m.  Blood culture: 
0.5 cc. in broth, Pneumococcus Type  I;  0.5  cc.  in  agar  plate,  1,000 colonies 
(approximately) of Pneumococcus Type I.  4  p.m.  Appears sick; offers little 
resistance to  handling;  respiration  s not increased.  Blood culture: one loop on 
surface of blood agar plate, 18 colonies of Pneumococcus Type I.  Mar. 11, 10.45 
a.m.  Appears better; more active.  Blood culture: 0.1 cc. in broth, Pneumococcus 
Type I; 0.5 cc. in agar, 510 colonies of Pneumococcus Type I.  4.30 p.m.  X-ray 
of chest.  There is no evidence of consolidation in the chest.  Mar. 12,, 10 a.m. 
Appears well and active.  Blood culture: 0.5 cc. in broth, Pneumococcus Type I; 
0.5  cc. in agar plate, 151 colonies of Pneumococcus Type I.  Mar. 13, 10.30 a.m. 
Appears welland active.  Blood culture: 0.5  cc.  in  broth,  Pneumococcus Type 
I; 0.5 cc. in agar plate, 11 colonies of Pneumococcus Type I.  Mar. 14, 11  a.m. 
Well  and  active.  Blood  culture: 0.5  cc.  in broth,  no growth; 0.5 ~c. in  agar 
plate, no growth.  Mar. 15.  Well and active.  Mar. 27.  Well and active.  Mon- 
key bled  (10 cc.).  Serum tests with  Pneumococcus  Type  I:  Agglutinins, 0. 
Protection, 0.0001  cc., survived; 0.00001 cc., survived; 0.000001 cc., survived 4½ 
days.  Control, 0.00001 cc.,  died in 48 hours; 0.000001 cc., died in 48 hours. 660  EXPEE IM-E.NTAL  PNEUMONIA.  V 
Text-fig.  1  shows  the  temperature,  leucocyte,  and  blood  culture 
curves following vaccination.  There was a  sharp rise of temperature 
in response to the injection, but the leucocytes were unaffected.  The 
most  striking  feature  of  the  chart  is  the  blood culture  curve.  The 
pnettmococci invaded the blood stream within 3 hours after vaccination, 
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TExT-FIG. 1. Monkey 7.  Reaction following  subcutaneous inoculation of 0.001 
cc. of broth culture of living virulent Pneumococcus Type I. 
and by the end of 24 hours there were nearly  1,000  pneumococci per 
0.5  cc. of blood.  In spite of this septicemia, however, the monkey did 
not  appear  seriously ill  at  any time.  The  blood cleared up rapidly, 
the temperature .dropped,  and  5 days after  vaccination  the  monkey 
appeared well and active.  It is surprising that a  heavy septicemia of 
this kind could have been associated with such mild clinical symptoms. RUSSELL L. CECIL AND  FRANCIS G. BLAKE  661 
It is also noteworthy that 20 days after vaccination the serum of this 
monkey protected mice against  1,000  times the minimal lethal dose of 
Pneumococcus Type I. 
Experiment 2.--Apr. 15, 1919.  Three Macacus syrichtus monkeys (Nos. 46, 47, 
and 48) were inoculated with a living virulent Pneumococcus Type I, each receiv- 
ing the  same  dose  that  Monkey 7 received--0.001 cc. of  broth  culture  sub- 
cutaneously.  Condensed protocols are shown in Table I and Text-fig. 2. 
TABLE 1. 
Effect of Subcutaneaus Injection of Living Culture of Virulent Pneumococcus Type I. 
16 
t7 
~8 
Weight. 
I  gin. 
12,550 
2,710 
I 
i 
! 
3,590 
Apr. 15. 
Broth 
culture 
of Pn. I 
subcuta° 
neously. 
Co. 
0.001 
0.001 1: 
0.001 
Apr. 29.  Serum tests with Pn. I. 
Agglu- 
tinins. 
1++[ 
Protection. 
0.00001 cc. 
S.* 
0.000001 cc. 
S. 
0.0000001 
co. S. 
Control. 
0.00001 cc. 
D. 24 hrs. 
0.000001 cc. 
D. 36 hrs. 
0.0000001 
cc.  D. 36 
hrs. 
Result.  Autopsy. 
D. 4 days.  Lungs 
normal. 
Remained 
weU. 
Remained 
well. 
Autops) 
cultures 
Heart's 
blood. 
Pn. I 
* S. indicates survived; D., died. 
It will be observed that each of these three monkeys reacted differ- 
ently to the vaccine.  The smallest one (Monkey 46) showed a severe 
constitutional  reaction  with heavy septice~nia,  and  died  on  the  4th 
day.  Monkey 47 reacted with a sharp but temporary rise in temper- 
ature and leucocytes, but the blood remained  sterile and the monkey 
at no time appeared ill.  The largest monkey (No. 48) showed no re- 
action of any kind except a slight leucocytosis. 
2 weeks after vaccination  the two surviving monkeys were bled and 
their  sera  tested  for agglutinins  and  protective bodies against  Pneu- 
mococcus Type I.  Monkey 47 showed both agglutinins and protective 
substances.  Its serum  protected  mice against  100 times the minimal 
lethal dose of Pneumococcus Type I.  Monkey 48, on the other hand, 662  EXPEI%TMENTA~  PNEUMONIA.  V 
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exhibited neither agglutinins nor protective bodies.  These reactions 
indicate what a  large factor  individual variation may be in  experi- 
ments of this kind. 
Active Immunity Following Subcutaneous Injection of  Li~ing Viru- 
lent Pneumococd.--The immediate effect of subcutaneous injections of 
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TExT-FIG.  3,  d~ and b.  Active immunity against Pneumococcus Type I  fol- 
lowing vaccination with living virulent Pneumococcus Type I.  (a)  Monkey 7; 
received 0.001 cc. of living culture subcutaneously.  (b) Monkey 3;  control. 
living virulent  pneumococci having been studied, the next step was 
to  determine  the  degree of  immunity conferred by  this  method  of 
vaccination. 
The object of the two following  experiments was to test  the vac- 
cinated monkeys for active immunity against Pneumococcus Type I. 654  EXPEI~IMENTAL  PNEUMONIA.  V 
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The identical  strain  of  Pneumococcus Type I  was used  for  the  in- 
tratracheal  injections  that  had  been  used  for  the  subcutaneous 
vaccinations. 
Experiment 3.--Mar.  28,  1917.  Monkey 7,  21  days  after  vaccination with 
living virulent  Pneumococcus Type  I,  was  injected  intratracheaUy  with  0.1 
cc. of an  18  hour  Pneumococcus Type I  broth culture.  No monkey of this 
species was available as an actual control at the time.  The record of Monkey 3, 
however, is introduced to indicate what had been the invariable result when com- 
parable  doses of Pneumococcus Type I  were injected intratracheally  in normal 
unvaccinated  capucinus monkeys.  The temperature,  leucocyte, and blood cul- 
ture curves are charted in Text-fig. 3.  The results are shown in Table II. 
The  vaccinated monkey  (No.  7), though it  received  100,000  times 
the minimal infecting dose, remained perfectly well, while Monkey 3 
died with incipient  lobar pneumonia  and  an  overwhelmiflg pneumo- 
coccus septicemia on the day following injection.  Even the leucocyte 
count in Monkey 7  remained  unchanged. 
In other words, a very small quantity of living virulent pneumococ- 
cus culture (0.001  cc.) injected subcutaneously was sufficient to confer 
on the monkey a  high degree of active immunity against the homolo- 
gous strain. 
One of the Macacus monkeys  (No. 48) which had been vaccinated 
with living  virulent  pneumococci (0.001 cc.)  was next tested.  7 
Experiment  4.--Apr.  30, 1919. Monkey 48,  vaccinated  on Apr.  15 with  0.001 
cc.  of  living  Pncumococcus Type I,  and Monkey 83, control,  were each  injected 
intratracheally  with  0.001  cc.  of  Pneumococcus Type I  broth  culture. 
The protocols (Table III and Text-fig.  4) show that the vaccinated 
monkey remained active and well.  The control developed a typical 
lobar pneumonia and died on the 8th day with the usual pneumococcus 
septicemia.  As in the previous experiment,  the vaccinated monkey 
showed  no  rise in  temperature  and  did not  even  react with  a 
leucocytosis. 
There was, .however, a  difference between the vaccinated monkey in 
Experiment  3  and  the one in Experiment  4.  The  former developed 
a  considerable axnount of protective substance in the blood following 
vaccination;  the  latter  showed  none.  Yet  both  were  immune  to 
Pneumococcus Type I  pneumonia. 
Monkey 47 will be considered later. 666  EXPERIMENTAL  PNEUMONIA.  V 
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TABLE  IIL 
Active Immunity Following Subcutaneoua Injection of a Living Culture of Virulent 
Pneumococeus Type I. 
~  Weight. 
gm, 
t8  3,590 
~3  2,470 
Apr. 15. 
Broth cul- 
ture of Pn. 
I subcuta- 
neously° 
¢$. 
0.001 
Apr.30. 
Broth cul- 
tureofPn. 
I intrs- 
tracheally. 
cG. 
0.001 
0.001 
May 2.  Result.  X-ray. 
Negative.  No  signs  of 
pneumo- 
nia.  Re- 
mained 
we]], 
C~nical 
pneumo- 
nia.  D. 
8th day. 
Autopsy. 
Lobar pneu- 
monia, 
R. U.,R. 
M., R. L.* 
Autopsy  cultures 
Lung,  Heart's 
blood. 
Pn.I  Pn.I 
*R. L., R. M., R. g., etc., indicate lobes of the lung.  The cardiac lobe is in- 
cluded as part of the right lower lobe. 
Cross-Immunity  against  Pneumococcus  Type H  Following  Vaccina- 
tion  with  Living  Virulent  Pneumococcus  Type  /.--The  experiments 
just reported afford ample Woof that vaccination with a living virulent 
Pneumococcus Type I  stimulates  a  high degree of active immunity 
against  the homologous type of pneumococeus.  The next step was 
to determine whether vaccination with living Pneumocoecus Type I 
afforded any cross-immunity against the other types of pneumonia.  1 
week, therefore, after the test against Pneumoeoceus Type I, Monkey 
7 was tested against a virulent strain of Pneumocoeeus Type II. 
Experiment 5.--Apr.  4,  1919.  Monkey 7, vaccinated  against Pneumococcus 
Type I, and Monkey 25, control, were injected intratracheally  with 0.1 cc. of 
broth culture of Pneumoeoccus Type II (Table IV, Text-fig. 5).  Monkey 7 re- 
mained perfectly well, with no rise in temperature or leucocytes.  Monkey 25, 
the control, developed lobar pneumonia with leueocytosis and positive blood 
culture.  The control recovered by crisis on the 7th day. 
According  to  this  experiment vaccination  with  a  living  virulent 
Pneumoeoceus Type I  had conferred not only immunity against the 
homologous type but  a  cross-immunity against Pneumococcus Type 
II  as well.  Furthermore,  this immunity existed in  spite  of the  ab- 
sence of protective bodies against Pneumococcus Type II in the serum 
of the monkey. 668  EXPERIMENTAL  PNEUMONIA.  V 
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TABL~  IV. 
Production of  Cross-Immunity  ~th  a  Living  Culture of  Virulent  Pneumococcus 
Typ* L 
d 
.~5 
Weight. 
I  ]  ' 
gra. 
1,430 
:  740 
Mar. 31. 
Serum tests Apr. 4. 
with Pn. II.  Broth 
culture 
of Pn. 
~  .  II intra- 
"~.~  o ta  trache-  ~O  "~.~  .-  ally. 
CC. 
0  0  0.1 
0.1 
Apr. 7. 
X-ray. 
Negative. 
Shadow, 
R.U. 
Result. 
Remained 
well. 
Clinical 
pneumo- 
nia.  Cri- 
sis on 7th 
day. 
Killed. 
Autopsy. 
Lobar pneu- 
monia, R. 
U.;  gray 
stage. 
Autopsy  cultures. 
Lung. 
Sterile. 
Heart's 
blood." 
Sterile. 
Exper/men~ 6.--June 24, 1919.  8 weeks after the test against Pneumococcus 
Type I, Monkey 48, vaccinated against Pneumococcus  Type I, and Monkey 91, 
control, were  injected intratracheally with 0.1 cc. of broth culture of Pneumococcus 
Type II (Table y~ Text-fig. 6). 
Both monkeys developed Type II pneumonia and both recovered. 
In  the  vaccinated monkey, however,  the  disease  ran  a  mild  short 
course,  and  the blood was  sterile  throughout practically the  entire 
course of the disease.  The control monkey ran a long course (crisis on 
the 18th day) and showed a fairly heavy pneumococcus septicemia. 
In  the  case,  then,  of  Monkey 48  successful vaccination  against 
Type I  pneumonia did not give sufficient cross-immunity to protect 
against Pneumococcus Type II pneumonia, though it did apparently 
moderate the severity of the disease.  The inconsistency between the 
results obtained in Experiments 5 and 6 may be explained in several 
ways.  In Experiment 5,  the test for cross-immunity against Pneu- 
mococcus Type II was made 1 week after  the  test against Pneumo- 
coccus Type I; in Experiment 6 the test for cross-lmmunity was car- 
ded out 8 weeks after testing for homologous immunity.  The dura- 
tion of pneumococcus immunity is not known, but a  high degree of 
resistance lasts probably not more than a few months.  Another ex- 670  EXPERIMF.NTAL  PNEUMONIA.  V 
planation  may  be  found  in  the  much  severer reaction  exhibited  by 
Monkey 7 following vaccination,  with a  consequent development of a 
higher  grade of immunity.  Still  another  and  perhaps more rational 
explanation  would interpret  this difference in cross-immunity to indi- 
vidual variation  in  the monkeys. 
TABLE  V. 
Experimental  Pneumococcus Type  II  Pneumonia Following  VacdnaHon  with  a 
Living Culture of Virulent Pneumococcus Type I. 
Monk¢ 
No. 
48 
91 
(con- 
trol). 
Weight 
glM. 
3,590 
4,002 
9,  Apr. 30. 
,.,  ~'~ 
001  Resisted in-  0 
fection 
with  Pn. 
I  intra- 
tracheally. 
0 
June 23.  Serum tests with Pn. II. 
Protection.  Control. 
0.000001 cc.  0.00(01  cc. 
S.  D. 48 hrs. 
0.00001  cc.  0.00001  cc. 
S.  D. 20 hrs. 
0.0001  cc.  0.0001 cc. 
D. 48 hrs.  D. 18 hrs. 
0.001 cc. D. 
48 hrs. 
June 24.1 
Broth 
[ culture  [ 
Jof Pn. II[ 
|  intra-  [ 
CO. 
0.! 
0.1 
Result. 
Clinical 
pneumonia. 
Recovery 
by crisis 
on 8th day. 
Clinical 
pneumo- 
nia.  Re- 
covery on 
18th day. 
There is one more interesl£ug  feature  to this  experiment.  It  will 
be recalled  that  Monkey 48,  though immune to Pneumococcus Type 
I  pneumonia  showed no protective  substance in  the  blood.  When, 
however, 8 weeks later a second protection test was carried out on the 
serum  of this monkey,  this  time  against  Pneumococcus  Type II,  a 
definite  though slight amount  of protection was  demonstrated.  We 
offer no explanation of this phenomenon. ~  * 
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Cross-Immunity against Pneumococcus Type III Following Vaccina- 
tion with Living Virulent Pneumococcus Type I.--The last  two experi- 
ments (Nos. 5 and 6) gave some evidence of a  cross-immunity against 
Pneumococcus  Type  II  following  vaccination  with  living  virulent 
Type I pneumococci.  It was decided, therefore, to determine whether 
a  similar  cross-protection  existed  against  Pneumococcus Type  III. 
TABLE  VI. 
Production  of Cross-Immunity  with  a  Living  Culture  of  Virulent  Pneumococcus 
Type I. 
I  Apr.  29.  . 
Serum tests 2~pr. #, 
with Pn.  Brott 
III  I cultur 
5  ....  of Pn  May 3. 
Z  Weight.  ~  ,  III  X-ray. 
~  ~.~  intra- 
"~  ~',~  2  ~  trache 
=o  ~'= ~=  ~ly. 
g,~l.  ¢C. 
1,430  0  0  0.1  Negative. 
732 
i 
,  ! 
0.1  82  Shadow, 
R.U. 
Result.  Autopsy. 
Temporary 
febrile re- 
action; no 
pneumo- 
Ilia. 
Clinical  Interstitial 
pneumo-  pneumo- 
nia.  Cri-  nia, R. U 
sis on 7th 
day. 
Killed. 
Autopsy cultures 
Sterile.  Sterile. 
Experiment 7.--Apr.  30, 1919.  About 4  weeks after the test against  Pneumo- 
coccus Type II, Monkey 7, vaccinated with living culture of Pneumococcus Type 
I, and Monkey 82, control, were injected intratracheally with 0.1 cc. of broth cul- 
ture of a virulent  Pneumococcus Type IlL  The  results  are shown  in  Table  VI 
and Text-fig. 7. 
The vaccinated monkey reacted  to the injection of  Pneumococcus 
Type nI with a sharp but temporary rise of temperature, and a slight 
increase  in  leucocytes.  The  blood  culture  remained  sterile.  The 
monkey appeared sick during the afternoon of the day on which it was 
injected, but the next morning it was lively and well and remained so. 
The  x-ray  was  negative,  and  if  any  pneumonia  developed it  must I~USSELL  L,  CECIL  AND  ]~RANCIS  G.  BLAI~  673 
~m.s,-ooococca  ,:,r..~  o..)cc,  or  m_ooo 
I:I)  •  [  ,  ~I. 
i  fi  • 
~  11~,  ,'  ,  ." 
-I~1  "-!  "  " 
I~-I  "~  ,  '  "~. 
;  i  !  ; 
|~illi 
IBmili 
gRilil 
D~5iii 
ammm 
mmmm 
ammm 
ammm_, 
L~ 
\ 
,~  ~oo  o  ~1=1~1  .......  "-7 
3~ n..L~:~l~. 
r~v~ 
8 
,-..i 
U 
~.~° 
l::l 674  EXPERIMENTAL  PNEUMONIA.  V 
have been an exceedingly small patch.  On the other hand, the control 
monkey developed a definite but rather mild attack of Type In pneu- 
monia, with moderate leucocytosis and positive blood culture.  The 
control recovered by crisis on the 7th day and autopsy showed a  re- 
solving interstitial pneumonia. 
Vaccination with a living virulent Pneumococcus Type I  apparently 
gave Monkey 7  a  certain amount of cross-immunity  against  Pneu- 
mococcus Type nI  as well  as  against  Type  II.  As with  Pneumo- 
coccus Type II,  the  monkey possessed no  demonstrable protective 
bodies in the blood against Pneumococcus Type III. 
Test for  Cross-Immunity  against  Pneumococcus  Type  IV  Following 
Vaccination  with Living  Virulent Pneumococcus  Type/.--One  of  the 
TABLE  VII. 
Experimental Pneuraococcus Type IV Pneumonia Foll~ving Vaccination with a 
Living Culture of Virulent Pneumococcus Type I. 
d 
dNI 
Lll 
Weight. 
1,430 
2,219 
May 271 
Broth 
culture 
of  Pn. 
IV 
intra- 
trachc- 
ally. 
0.I 
0.1 
June 5. 
X-ray. 
Negative. 
i  Shadow, 
R.L. 
Result. 
Clinical 
pneumo- 
nia.  Re- 
covely by 
lysis  on l 
8th  day. 
Killed  on 
14th day. 
Clinical 
pneumo- 
nia.  Re- 
covery on 
14th day. 
Autopsy. 
Resolving 
lobar 
pneumo- 
nia, R. L., 
L.L. 
Autopsy cultures. 
Lung.  Heart's  blood. 
No growth.  No growth. 
1 
vaccinated  monkeys  (No.  7)  had  resisted  Pneumococcus  Type  I, 
Type II, and probably Type III pneumonia.  It remained, therefore, 
only to test it against Pneumococcus Type IV.  In this test a strain 
of Type IV was employed that had been recently isolated from a  case 
of spontaneous Pneumococcus Type IV pneumonia in one of the stock 
monkeys (No. 97). RUSSELL  L.  CECIL  AND  FRANCIS  O.  BLAKE 
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Experiment 8.--May 27, 1919.  4 weeks after being tested for immunity against 
Pneumococcus Type nI, Monkey 7, vaccinated,  and Monkey 111, control, were 
injected intratracheally  with 0.1 cc. of broth culture of Pneumococcus Type IV 
(Strain M 97).  Table VII and Text-fig. 8 show the results of the experiment. 
Both monkeys developed Type IV pneumonia  with high tempera- 
ture,  leucocytosis, pneumococcus septicemia,  and final  recovery; but 
the vacdnated monkey was well on the 8th day, while the control did 
not recover until the 14th day. 
Apparently,  there  was  not  enough  cross-immunity  to  protect  the 
Vaccinated  animal  against  pneumonia,  though  there  was  enough,  as 
with Monkey 48 in Experiment 6,  to moderate and shorten somewhat 
the course of the disease.  Just why Monkey 7 resisted the three fixed 
types of pneumococcus and then became infected with a Pneumococcus 
Type IV it  is hard  to say.  Nearly  3  months had  elapsed  from  the 
day  of  vaccination  to  the  day  when  the  monkey was  injected with 
Pneumococcus Type IV, and it may be that by that time the immunity 
curve was on the downward way.  Moreover, the pneumococcus used 
had  recently  been  isolated  from  another  infected monkey,  and  was 
therefore  adapted,  in  a  sense,  to  the  species.  The  fixed  strains  of 
pneumococcus used had never been passed through  monkeys. 
Spontaneous  Pneumococcus  Type  IV  Pneumonia  Following  Vacci- 
nation  with  a  Living  Virulent  Pneumococcus  Type  /.--The  following 
case  corroborates  the  evidence  obtained  in  the  last  experiment; 
namely, that there is not much cross-protection against Pneumococcus 
Type IV pneumonia  in  monkeys  following vaccination with  a  living 
virulent culture of Pneumococcus Type I. 
Experiment 9.--Monkey 47.  Macacus  syrichtus, male; weight 2,170 gm.  Apr. 
15, 1919, I0 a.m.  Vaccinated with 0.001 cc" of 18 hour broth culture of Pneumo- 
coccus Type I  (see Experiment 2).  Apr. 30.  Well  and active.  May 1.  Looks 
sick; rapid labored respiration.  May 2.  Blood culture, Pneumococcus Type IV. 
May 3.  Bronchial breathing  in left axilla.  May 4.  Dyspnea persists;  cough. 
May 5.  Condition the same.  May 9.  Crisis  and recovery.  May 10.  Killed. 
Autopsy.--Resolving lobar pneumonia, left middle and lower lobes and right 
middle lobe; acute fibrinous pleuritis, left. 
Text-fig.  9  shows  the  temperature,  leucocyte,  and  blood  culture 
curves  of  this  case  of  spontaneous  pneumonia.  The  disease  ran  a 
typical course, very similar to that  seen in the experimental pneumo- RUSSELL L.  CECIL AND  FRANCIS G.  BLAKE  677 
nia  of  monkeys.  The  blood,  however,  remained practically sterile 
(only one positive blood culture), and this fact suggests that here as 
in  Monkey  7,  Pneumococcus  Type  I  vaccination afforded  enough 
cross-immunity against Pneumococcus Type IV to moderate the se- 
verity of the pneumonia caused by the latter organism. 
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TEXT-FIG. 9.  Monkey 47.  Spontaneous Pneumococcus Type IV pneumonia in 
a monkey vaccinated with living virulent Pneumococcus Type I.  Received 0.001 
cc. of living culture of virulent Pneumococcus Type I subcutaneously. 
Vaccination  with a Li~ing A~rulent Culture  of Pneumococcus. 
Lip to this point all the experiments reported  have  shown  the  re- 
sults  obtained by vaccination with a  living  virulent pneumococcus. 
The remainder of the vaccination experiments were carried out with 678  EXPERIMENTAL  PNEUMONIA.  V 
a  living  avimlent  pneumococcus, in order  to deterrn~ne  how impor- 
tant a  factor virulence was, on the one hand, and, on the other, how 
much depended upon the use of living or killed cultures. 
l: 
Jo#.Y 
8  3 
\ 
ii  !! 
/o  /size  /J 
i 
1  e 
,¢ 
tt 
C 
I 
st 
]z  /2  /,y 
t 
.| 
i 
t 
J~ 
b 
I 
! 
# 
TExT-FIo. 10, a  and b.  Reactions following the subcutaneous  inoculation of 
living avirulent Pneumococcus Type I.  (a)  Monkey 117; received 1 cc. of living 
culture subcutaneously.  (b)  Monkey 118;  received 2 cc. of living culture subcu- 
taneously. 
The culture used for vaccination in the following experiments was 
an  old  stock Pneumococcus Type I  which was avirulent for mice in 
doses of 1 cc. of broth culture.  This strain was used for the prepara- 
tion of the vaccine in the study of vaccination with killed cultures,  s 
s Blake, F. G., and Cecil, R. L., J. Exp. Med., 1920, xxxi, 499. RUSSELL  L.  CECIL'AND  FRANCIS  G.  BLAKE  679 
It was assumed that in view of the lack of virulence a much larger 
dose of vaccine would be necessary in order to obtain results;  conse- 
quently, a  dose of 1 to 2 cc, of broth culture was employed.  The injec- 
tions were given subcutaneously in the abdominal wall as in  the pre- 
v/ous experiments. 
Experiment 10.--July  10,  1919.  Two Macacus syrichtus monkeys  (Nos. 117 
and  118) were injected  subcutaneously with  an  18 hour broth culture  of living 
avirulent  Pneumococcus Type I.  Monkey 117 received  1 cc. of culture (about 
300 million pneumococci).  Monkey 118 received 2 cc. (about 600 millon pneumo- 
cocci).  The reactions are shown in Text-fig. 10. 
Monkey  117  developed  a  small  area  of induration  at  the  site  of 
inoculation  but  had  no  constitutional  reaction  whatever.  Monkey 
118  also  showed a  slight  local  reaction,  and  in  addition  a  moderate 
rise  in leucocytes.  The  blood  remained  sterile  in  both monkeys. 
TABLE  VIII. 
Active Immunity Following Subcutaneous Injection of a Living Culture of Avlrulent 
Pneumococcus Ty be I. 
VIonkey 
No. 
117 
118 
127 
(con= 
troD. 
Weight 
2,565 
2,915 
2,700 
July 10.  [ 
Broth cul- 
ture of Pn.  Reaction. 
I subcu-  ' 
taneously. 
1  Slight; lo- 
cal. 
2  Slight; lo- 
cal. 
0 
July 24. 
Serum tests with 
Pn. I, 
fiAg~lu-  Protec- 
"ns,  tion. 
i 
0  0 
; 
0  0 
July 24. 
Broth culture 
of Pn. I i n- 
tratracheally. 
CO. 
0.000001 
0.000001 
0.000001 
Result. 
i 
Clinical pneumonia.  Re 
i  covery by crisis on 8tt 
day. 
Remained well 
Clinical pneumonia.  Re 
covery by crisis on 9t} 
day. 
This  experiment  indicated  that living avirulent  pneumococci  could 
be administered subcutanequsly in fairly large doses to monkeys with- 
out producing any serious local or general reaction. 
The following experiment was carried out for the purpose of testing 
the amount  of active immunity  produced by vaccination with living 
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Experiment//.--July 24,  1919.  Monkeys  117  and  118,  both vaccinated on 
July  10 with living avirulent pneumococci, and Monkey  127, control, were in- 
jected intratracheally with 0.000001 cc. of broth culture of Pneumococcus Type I 
(Table VIII).  Monkey 117, which received the small dose (1 cc.) of living vac- 
cine, developed a  mild pneumonia and recovered by crisis on the 8th day of the 
disease.  Monkey 118, which received the large dose (2 cc.) of living vaccine, re- 
mained perfectly well.  The control (Monkey 127) developed pneumonia and ran 
a typical course with crisis on the 9th day. 
Text-fig.  11  shows the  temperature,  leucocyte, and blood culture 
curves.  Monkey 118  pre~ented no  reaction of  any kind.  Monkey 
117 ran a  typical lobar pneumonia, with positive blood culture, high 
leucocytosis, and crisis on the 8th day.  Monkey 127  also ran a typi- 
cal course with crisis on the 9th day. 
Living avirulent pneumococci, when injected  subcutaneously,  ap- 
pear to excite an immunity equal in degree to that produced by living 
virulent pneumococci, if a large enough dose is administered.  In this 
experiment 1 cc. of broth culture of living avirulent pneumococci did 
not confer a sufficiently high degree of immunity to protect the mon- 
key from pneumonia.  When 2 cc., however, of the same culture were 
administered to another monkey, the protection was satisfactory.  In 
other words, the dose is a factor to be considered in vaccinating with 
living avirulent pneumococci. 
DISCUSSION. 
The inferences to be drawn from the experiments reported in this 
study are plain.  A high degree of immunity against pneumococcus 
pneumonia can be induced by  the  subcutaneous injection of living 
virulent pneumococci, but the method is too dangerous for any sort 
of  practical  application.  Vaccination with  attenuated  living pneu- 
mococci could probably be practised with impunity, but the problem 
of transporting and keeping alive large quantities of pnetumococci in 
the field would be difficult to solve.  The fact that a higher degree of 
immunity is produced by living pneumococci than by dead  pneumo- 
cocci is not surprising in the light of previous observations on vacci- 
nation with other bacteria.  The degree of cross-immunity, however, 
which sometimes followed  vaccination with living Pneumococcus Type 
I  was surprising and confirms the fact already established that  the 
various types of pneumococci are closely related biologically. 682  EXPERIMENTAL  PNEUMONIA.  V 
This study had suggested a  number of theoretical problems.  In 
the first place, why do living pneumococci confer a more efficient im- 
munity than  dead  pneurnococci?  Virulence  appears  to  play  some 
part, but even with aviruler~t strains good protection can be secured 
with  sufficiently large doses.  These animals vaccinated with living 
cultures are, of course, in a sense infected, and we are accustomed to 
think  of  infection  as  bestowing  a  more  efficacious  immunity than 
mere vaccination with killed cultures. 
The question also arises as to the significance of agglutinins and the 
so called protective bodies in an animal's blood.  It has been shown 
in the experiments reported that the serum of a monkey may be en- 
tirely free from these substances, and yet the animal may possess  a 
high grade of immunity against pneumonia.  On  the other hand, it 
was pointed out in the study of pneumococcus  saline vaccines  ~  that the 
serum of a vaccinated monkey might protect mice against 100  or even 
1,000 minimal lethal  doses  of pneumococci,  and  still  that  monkey 
be  susceptible  to  experimental  Pneumococcus  pneumonia.  These 
facts complicate the  whole  question of resistance to  pneumococcus 
infection and revive the  old problem of humoral versus  cellular  im- 
munity. 
These studies also emphasize the fact that "immunity" is a relative 
term and under any circumstances dependent on a number of factors. 
Every immunologist is familiar with the great differences  which ani- 
mals manifest in  their capacity to  produce antibodies.  Even with 
the most ideal methods of vaccination there will  always be  certain 
animals that respond poorly to  vaccine,  and  these animals will not 
possess the same amount of immunity that others will have. 
Furthermore, the  degree of immunity against  a  certain microor- 
ganism depends in large measure on the virulence of the strain used 
in  testing it.  For example, in  the  experiments on  cross-immunity, 
Monkey 7 resisted infection with Pneumococcus Type III which was 
not  very virulent for monkeys, but  Could not resist  Pneumococcus 
Type IV  which, in  this particular instance, happened to be virulent 
for monkeys.  In  view  of  this  fact  the  question  arises  whether in 
the  experiments with  Pneumococcus Type I  lipovaccine and  saline 
vaccine immunity would not have been demonstrated if a less virulent 
strain of Pneumococcus Type I  had been used for testing the efficacy 
of the vaccine. RUSSELL  L.  CECIL  AND  ~'RANCIS  G.  BLAKE  683 
All that has been said regarding virulence applies with equal force 
to the size of the infecting dose.  Even in well immunized monkeys 
experimental pneumonia could probably have been induced if  a suf- 
ficiently large  dose  of  culture  had  been  injected into  the  trachea. 
This would have been a  most artificial procedure, but the argument 
holds in spite of that fact.  The animal possesses a  definite sum of 
resistance, and when that sum is spent it becomes at once susceptible 
to infection. 
CONCLUSIONS. 
I.  The  subcutaneous  injection  of  small  doses  of  living  virulent 
Pneumococcus Type I  stimulates in monkeys a  degree of active im- 
munity sufficient to protect them against experimental pneumococcus 
pneumonia of homologous type. 
2.  The  subcutaneous  injection  of  living  avirulent  Pneumococcus 
Type I, if administered in a sufficiently large dose, likewise renders the 
monkey immune to a subsequent pneumonia of homologous type. 
3.  Vaccination  of  monkeys  with  mnall  doses  of  living  virulent 
pneumococci may or may not be followed by a  severe constitutional 
reaction, depending on the natural resistance of the individual.  The 
severe reactions are  caused by  the development of a  pneumococcus 
septicemia, which is either temporary, or leads to a fatal termination. 
The mild reactions are not accompanied by septicemia, and there are 
no symptoms other than a slight elevation of temperature and moder- 
ate leucocytosis.  Vaccination with living avirulent pneumococci does 
not induce severe reactions and is not accompanied by pneumococcus 
septicemia. 
4.  Active  immunity against  pneumococcus pneumonia,  produced 
by  vaccination with  living  pneumococci, appears  to  be  largely in- 
dependent of the presence  or  absence of agglutinins and  protective 
bodies in the serum of the monkey. 
5.  Vaccination with living cultures of Pneumococcus Type I  con- 
fers  against other types of pneumococci a  certain amount of cross- 
immunity which,  however,  varies  considerably with  the  individual 
monkey. 
6.  Immunity against pneumococcus, like other forms of immunity, 
is a relative term, and depends upon the capacity of the individual for 
antibody production, the virulence of the invading microorganism, and 
the size of the dose injected. 